24th May 2021 11:57
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 21 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,813,515 | 1.41% | 167,748 | 0.13% | ||
(2) | Derivatives (other than options): | ||||
72,359 | 0.06% | 94,581 | 0.07% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
| TOTAL: | |||||
1,891,974 | 1.47% | 268,429 | 0.21% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 3 | 262.9600 USD |
Purchase | 9 | 263.0666 USD |
Purchase | 15 | 263.4700 USD |
Purchase | 97 | 264.4200 USD |
Purchase | 100 | 264.0600 USD |
Purchase | 133 | 264.3500 USD |
Purchase | 170 | 263.9419 USD |
Purchase | 200 | 263.1012 USD |
Purchase | 202 | 262.9215 USD |
Purchase | 239 | 263.9158 USD |
Purchase | 250 | 264.0340 USD |
Purchase | 290 | 263.1782 USD |
Purchase | 307 | 263.7812 USD |
Purchase | 308 | 263.6800 USD |
Purchase | 326 | 264.4056 USD |
Purchase | 400 | 263.8212 USD |
Purchase | 490 | 264.3488 USD |
Purchase | 866 | 264.2366 USD |
Purchase | 1,000 | 263.7665 USD |
Purchase | 1,186 | 263.0547 USD |
Purchase | 1,530 | 262.8096 USD |
Purchase | 1,603 | 264.0378 USD |
Purchase | 1,655 | 263.1947 USD |
Purchase | 1,880 | 263.4432 USD |
Purchase | 2,043 | 263.1169 USD |
Purchase | 2,258 | 263.5605 USD |
Purchase | 2,700 | 263.7911 USD |
Purchase | 2,772 | 263.2022 USD |
Purchase | 3,236 | 263.6926 USD |
Purchase | 3,594 | 263.4900 USD |
Purchase | 6,368 | 263.7696 USD |
Purchase | 13,185 | 262.8100 USD |
Purchase | 16,627 | 262.8212 USD |
Purchase | 36,600 | 264.1745 USD |
Purchase | 47,858 | 262.9367 USD |
Sale | 42 | 263.9847 USD |
Sale | 61 | 264.0485 USD |
Sale | 72 | 264.0400 USD |
Sale | 100 | 264.0800 USD |
Sale | 130 | 263.9792 USD |
Sale | 170 | 263.9419 USD |
Sale | 185 | 264.1043 USD |
Sale | 240 | 263.5366 USD |
Sale | 250 | 264.0340 USD |
Sale | 285 | 263.7100 USD |
Sale | 400 | 263.8212 USD |
Sale | 400 | 264.0350 USD |
Sale | 501 | 264.0182 USD |
Sale | 554 | 263.4900 USD |
Sale | 600 | 264.2150 USD |
Sale | 819 | 263.7155 USD |
Sale | 1,046 | 264.3733 USD |
Sale | 1,265 | 264.2446 USD |
Sale | 1,450 | 263.3925 USD |
Sale | 1,458 | 263.6282 USD |
Sale | 1,530 | 262.8096 USD |
Sale | 1,696 | 263.9933 USD |
Sale | 1,863 | 264.1502 USD |
Sale | 2,812 | 262.8113 USD |
Sale | 3,174 | 263.1779 USD |
Sale | 4,215 | 263.6716 USD |
Sale | 11,028 | 264.1743 USD |
Sale | 14,856 | 263.1415 USD |
Sale | 19,532 | 262.8100 USD |
Sale | 25,172 | 264.1767 USD |
Sale | 50,964 | 262.9548 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 24 May 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210524005388/en/
Copyright Business Wire 2021
Related Shares:
Barclays